AUAUniversity

AUA2018 Take Home Messages Minimally Invasive Surgery Presented by: Jean Joseph, MD University of Rochester Medical Center Imaging Presented by: Simpa Salami, MD, MPH University of Michigan

Take Home Messages from AUA2018 in Pediatrics presented by Emilie Johnson, MD, MPH. In addition Plenary Next Frontier presentations in the area of pediatric urology Highlights: Society for Pediatric Urology presented by Caleb Nelson, MD, MPH Journal of Urology Highlights: Pediatrics presented by Julian Wan, MD

This podcast was developed from content delivered during the Use of Novel Hormonal Agents and Systemic Therapy in Advanced Prostate Cancer live course. Topics covered include: Practical Guide to an Advanced Prostate Cancer Clinic, Presented by Lawrence I. Karsh, MD, FACS Biomarkers for Advanced Prostae Cancer: Ready for Prime Time?, Presented by Daniel W. Lin, MD Acute and Chronic Pain Management...

Immuno-Oncology: A Focus on Prostate Cancer is the fourth webcast in the 4-part series. Topics will include "review of treatment options for advanced disease", "evolution of AR-directed treatment and chemotherapy" as well as "impact of immunotherapy on treatment of advanced disease". CME Available: https://auau.auanet.org/node/21419

AUA2018 Residents Forum - The Evolving Practice Of Urology by American Urological Association

AUA2018 Residents Forum - Wellness Burnout And Sustaining Your Career by American Urological Association

Immuno-Oncology: A Focus on Kidney Cancer is the third in the 4-part series. Topics will include "Review of Treatment Options for Systemic Disease", "Cytoeduction Debate" and "Impact of Immunotherapy on Treatment". CME Available: https://auau.auanet.org/node/21355

Sequencing of Chemotherapy and Immunotherapy in Advanced Prostate Cancer: Present and Future is the fourth and final in a 4-part series. Topics will include "Role of Chemotherapy and Performance Status and Pain Management" and "Treatment Sequencing, Immunotherapy and Future Approaches". CME Available: https://auau.auanet.org/node/19911

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webin...

Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and "future directions and biomarkers" of both. CME Available: https://auau.auanet.org/node/21348

Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webin...

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal Antibodies" and "Checkpoint Inhibitors". CME Available: https://auau.auanet.org/node/21336

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthesis Inhibitors and Androgen Receptor Signaling Agents" and "Radionuclide Therapy and Bone Health". CME Available: auau.auanet.org/node/19909 Release date:

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webin...

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation are producing a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary AUA Castration-Resistant Prostate Cancer Guid...

Take Home Messages from AUA2018 Infertility / Andrology Lawrence Jenkins, MD, MBA The Ohio State University Sexual Dysfunction Nelson Bennett, Jr., MD, FACS Northwestern University Feinberg School of Medicine

Take home messages from AUA2018 Endourology/Stones: Zeph Okeke, MD Infection/Inflammation: O. Lenaine Westney, MD, FPMRS

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary Emerging Treatment Options for Non-Metastatic...

In a webinar on Feb. 26, moderator Seth Cohen, MD, and panelists Gina Badaloto, MD, Moben Mirza, MD, Jessica Kreshover, MD, and Taylor Kohn (MS4) provide an overview on the application cycle to the Urology Match Program and offer advice for urology candidates seeking to maximize their efforts during this process. They also answer questions about the process for selecting away rotations and offer i...

Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines is the second podcast in a 4-part series. Topics will include “M0 CRPC: Emerging Treatment Options” and “MDC and Review of CRPC Guidelines”. CME Available: auau.auanet.org/node/19907

AUA2018 Take Home Messages Basic Sciences - Trauma by American Urological Association

The Changing Landscape of Advanced Prostate Cancer Management: What You Need to Know is the first podcast in a 4-part series. Topics will include "Initial Management and Imaging of Advanced Prostate Cancer" and "Chemo-hormonal Therapy for Metastatic Hormone-Sensitive Prostate Cancer ". CME Available: https://auau.auanet.org/node/19906

This course will include short didactic lectures followed by case presentations to give attendees an understanding of the many new FDA-approved agents, as well as existing standard therapies, for advanced prostate cancer-both non-metastatic and metastatic CRPC. Particular attention will be devoted to sequencing the new agents and positioning them as compared to older existing therapies. The cost e...

This course will provide a practical, evidence-based approach for the management of everyday problems in the management of prostate cancer, using a case-based approach with examples from real practice. Cases will illustrate contemporary management of early and late stage disease with emphasis on how new molecular diagnostic and prognostic tests (PCA3, MDx Confirm, Mitomics, Prolaris, Oncotype Dx P...